The Us Diabetic Devices Industry Outlook to 2018 - Growth to Be Led by Next Generation Technology

Submitted by: Submitted by

Views: 75

Words: 1611

Pages: 7

Category: Business and Industry

Date Submitted: 06/06/2014 04:18 AM

Report This Essay

The US Diabetic Devices Industry Outlook to 2018 - Growth to be Led by Next Generation Technology

The report titled “The US Diabetic Devices Industry Outlook to 2018- Growth to be Led by Next Generation Technology” presents a comprehensive analysis of the industry covering aspects including market size of SMBG devices, CGM systems and Insulin Delivery Devices market by revenue and market segmentation by product categories in SMBG devices and Insulin Delivery Devices market. The report also entails a detailed description on the recent trends and developments in the diabetic care devices market and competitive scenario of major players in the industry along with market share of major companies in SMBG devices and Insulin Delivery devices market. The Diabetic Care Devices Market in the US has transformed from niche to mainstream, owing to the increasing number of diabetic patients and growing ageing population in the country. Diabetic equipments have slowly become an integral part of present day’s fast paced lifestyles along with other changes such as increasing acceptability and affordability of these products. New product launches in this market has been driven by escalating demand of diabetic care devices by the diabetic population of the country. The US diabetic devices industry grew from USD ~ million in 2007 to USD ~ million in 2013, recording a CAGR of 7.7% from 2007-2013.This market is dominated by players such as Roche Diagnostics, Life Scan and Abbott Diabetes Care. The US Diabetic Care devices market has been predominantly held by SMBG devices, marking a contribution of nearly ~ % as recorded in 2013. The market share of this segment has decreased significantly from ~% in 2010 to ~% in 2013 but the segment continues to hold the largest share in the diabetic care devices market revenue in the country. The insulin delivery devices accounted for approximately ~ % of the diabetic care devices revenue in the country in the year 2013. CGM...